Rice Hall James & Associates, LLC Insmed Inc Transaction History

Rice Hall James & Associates, LLC

$1.69 Billion
Q3 2024

A detailed history of Rice Hall James & Associates, LLC transactions in Insmed Inc stock. As of the latest transaction made, Rice Hall James & Associates, LLC holds 93,492 shares of INSM stock, worth $6.6 Million. This represents 0.4% of its overall portfolio holdings.

Number of Shares

93,492

Previous 96,824 3.44%

Holding current value

$6.6 Million

Previous $6.49 Million 5.2%

% of portfolio

0.4%

Previous 0.42%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 28, 2024	SELL	$62.0 - $79.01 $206,584 - $263,261	-3,332 Reduced 3.44%	93,492 $6.82 Million
Q2 2024 Aug 07, 2024	SELL	$22.0 - $69.71 $1.82 Million - $5.75 Million	-82,508 Reduced 46.01%	96,824 $6.49 Million
Q1 2024 Apr 23, 2024	SELL	$25.72 - $29.94 $1.08 Million - $1.26 Million	-41,938 Reduced 18.95%	179,332 $4.87 Million
Q4 2023 Feb 08, 2024	SELL	$23.42 - $31.74 $74,826 - $101,409	-3,195 Reduced 1.42%	221,270 $6.86 Million
Q3 2023 Nov 02, 2023	SELL	$19.86 - $26.93 $95,864 - $129,991	-4,827 Reduced 2.11%	224,465 $5.67 Million
Q2 2023 Jul 24, 2023	SELL	$16.44 - $21.1 $28,934 - $37,136	-1,760 Reduced 0.76%	229,292 $4.84 Million
Q1 2023 May 11, 2023	SELL	$16.26 - $21.73 $268,891 - $359,349	-16,537 Reduced 6.68%	231,052 $3.94 Million
Q4 2022 Jan 27, 2023	SELL	$16.98 - $23.15 $22,770 - $31,044	-1,341 Reduced 0.54%	247,589 $0
Q3 2022 Nov 01, 2022	SELL	$20.88 - $28.21 $1.32 Million - $1.78 Million	-63,154 Reduced 20.24%	248,930 $5.36 Million
Q2 2022 Aug 08, 2022	BUY	$17.07 - $25.71 $613,410 - $923,888	35,935 Added 13.01%	312,084 $6.15 Million
Q1 2022 May 05, 2022	SELL	$20.42 - $28.13 $101,630 - $140,003	-4,977 Reduced 1.77%	276,149 $6.49 Million
Q4 2021 Feb 14, 2022	SELL	$25.89 - $33.45 $302,265 - $390,528	-11,675 Reduced 3.99%	281,126 $7.66 Million
Q3 2021 Nov 09, 2021	SELL	$22.46 - $29.47 $174,536 - $229,011	-7,771 Reduced 2.59%	292,801 $8.06 Million
Q2 2021 Jul 29, 2021	SELL	$24.17 - $36.01 $1.06 Million - $1.58 Million	-43,746 Reduced 12.71%	300,572 $8.55 Million
Q1 2021 May 14, 2021	SELL	$32.28 - $44.3 $565,932 - $776,667	-17,532 Reduced 4.85%	344,318 $11.7 Million
Q4 2020 Feb 16, 2021	SELL	$31.45 - $40.54 $3.78 Million - $4.87 Million	-120,157 Reduced 24.93%	361,850 $12 Million
Q3 2020 Nov 16, 2020	BUY	$26.0 - $34.5 $1.43 Million - $1.9 Million	55,111 Added 12.91%	482,007 $15.5 Million
Q2 2020 Aug 14, 2020	SELL	$14.11 - $29.42 $141,226 - $294,464	-10,009 Reduced 2.29%	426,896 $11.8 Million
Q1 2020 May 15, 2020	SELL	$13.63 - $33.98 $181,319 - $452,035	-13,303 Reduced 2.95%	436,905 $7 Million
Q4 2019 Jan 29, 2020	SELL	$16.12 - $24.98 $198,582 - $307,728	-12,319 Reduced 2.66%	450,208 $10.8 Million
Q3 2019 Oct 30, 2019	SELL	$15.49 - $25.78 $77,666 - $129,260	-5,014 Reduced 1.07%	462,527 $8.16 Million
Q2 2019 Aug 01, 2019	SELL	$23.0 - $32.19 $450,133 - $629,990	-19,571 Reduced 4.02%	467,541 $12 Million
Q1 2019 May 01, 2019	BUY	$13.91 - $31.15 $1.06 Million - $2.37 Million	76,038 Added 18.5%	487,112 $14.2 Million
Q4 2018 Feb 14, 2019	BUY	$11.6 - $18.7 $1.56 Million - $2.52 Million	134,620 Added 48.7%	411,074 $5.39 Million
Q3 2018 Oct 25, 2018	SELL	$18.95 - $28.08 $127,533 - $188,978	-6,730 Reduced 2.38%	276,454 $5.59 Million
Q2 2018 Aug 02, 2018	BUY	$20.0 - $29.72 $429,440 - $638,147	21,472 Added 8.2%	283,184 $6.7 Million
Q1 2018 Apr 25, 2018	BUY	$21.69 - $32.99 $5.68 Million - $8.63 Million	261,712 New	261,712 $5.89 Million

Others Institutions Holding INSM

# of Institutions

466

Shares Held

180M

Call Options Held

2.27M

Put Options Held

3.33M

View Full List

About INSMED Inc

Ticker INSM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 135,476,992
Market Cap $9.56B
Description
Insmed Incorporated, a biopharmaceutical company, develops and commercializes therapies for patients with serious and rare diseases. The company offers ARIKAYCE for the treatment of Mycobacterium avium complex lung disease as part of a combination antibacterial drug regimen for adult patients. It is also developing Brensocatib, an oral reversibl...

More about INSM

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Rice Hall James & Associates, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Rice Hall James & Associates, LLC with notifications on news.

Account

Rice Hall James & Associates, LLC Insmed Inc Transaction History